✨
AI Summary
- 95% of cancer treatments fail clinical trials, often due to poor patient-tumor matching.
- AI can improve matching, leading to higher success rates with existing treatments.
- Better matching could save millions of lives and revolutionize Big Pharma's approach.
Guests on This Episode
DB
Daniel Bear
doctoral candidate at the London School of Economics and Political Science · 1 podcast appearance
RA
Ron Alfa
1 podcast appearance